Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Richards

Showing results (181-190 of 736) with videos related to

Pageof 74
Sort By:
The American Journal of Cardiology|March 28, 2006
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart diseaseCara A Wasywich, Mark W I Webster, A Mark Richards, et al.
Stem Cells (Dayton, Ohio)|September 12, 2003
Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cellsMark Richards, Shawna Tan, Chui-Yee Fong, et al.
Clinical Biochemistry|February 8, 2020
Analytical and biological assessment of circulating human erythroferroneSarah Appleby, Janice Chew-Harris, Richard W Troughton, et al.
Chest|October 21, 2005
Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failureKatherine Ferrier, Angela Campbell, Brendon Yee, et al.
Journal of Cardiovascular Electrophysiology|July 16, 2021
A novel adaptive insertable cardiac monitor algorithm improves the detection of atrial fibrillation and atrial tachycardia in silicoSunipa Saha, David Perschbacher, Paul Jones, et al.
European Journal of Heart Failure|August 9, 2002
Plasma brain natriuretic peptide after long-term treatment for heart failure in general practiceGraham McGeoch, John Lainchbury, G Ian Town, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2007
Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertensionWilliam Kemp, Henry Krum, John Colman, et al.
Clinical Biochemistry|May 27, 2019
Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individualsJanice Chew-Harris, Sarah Appleby, A Mark Richards, et al.
International Journal of Molecular Sciences|April 9, 2016
MicroRNA and Heart FailureLee Lee Wong, Juan Wang, Oi Wah Liew, et al.
Lancet (London, England)|September 21, 2002
Plasma urotensin II in heart failureA Mark Richards, M Gary Nicholls, John G Lainchbury, et al.
Pageof 74

Showing results (181-190 of 736) with videos related to

Sort By:
Pageof 74
The American Journal of Cardiology|March 28, 2006
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart diseaseCara A Wasywich, Mark W I Webster, A Mark Richards, et al.
Stem Cells (Dayton, Ohio)|September 12, 2003
Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cellsMark Richards, Shawna Tan, Chui-Yee Fong, et al.
Clinical Biochemistry|February 8, 2020
Analytical and biological assessment of circulating human erythroferroneSarah Appleby, Janice Chew-Harris, Richard W Troughton, et al.
Chest|October 21, 2005
Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failureKatherine Ferrier, Angela Campbell, Brendon Yee, et al.
Journal of Cardiovascular Electrophysiology|July 16, 2021
A novel adaptive insertable cardiac monitor algorithm improves the detection of atrial fibrillation and atrial tachycardia in silicoSunipa Saha, David Perschbacher, Paul Jones, et al.
European Journal of Heart Failure|August 9, 2002
Plasma brain natriuretic peptide after long-term treatment for heart failure in general practiceGraham McGeoch, John Lainchbury, G Ian Town, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2007
Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertensionWilliam Kemp, Henry Krum, John Colman, et al.
Clinical Biochemistry|May 27, 2019
Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individualsJanice Chew-Harris, Sarah Appleby, A Mark Richards, et al.
International Journal of Molecular Sciences|April 9, 2016
MicroRNA and Heart FailureLee Lee Wong, Juan Wang, Oi Wah Liew, et al.
Lancet (London, England)|September 21, 2002
Plasma urotensin II in heart failureA Mark Richards, M Gary Nicholls, John G Lainchbury, et al.
Pageof 74